Amway (China) R&D Center participaed in the signing ceremony of the national key R&D program "modernization of traditional Chinese medicine" during the 13th Five-Year plan period.

The 14th National Nutrition Science Conference and the 11th Asia-Pacific Clinical Nutrition Conference as well as the 2nd Global Chinese Nutrition Scientists Conference were held in Nanjing from September 20 to 22, 2019. Under the theme of "nutrition research and clinical practice", the session aims to promote the implementation of the “Healthy China” strategy, reaching the health goals found in the National Nutrition Plan (2017-2030) ,and to enhance the academic communication and development in the filed of nutrition science in the Asia-Pacific region and the globle.

On the 22nd, Wang Linyuan, the chief scientist of the National R&D Program of the Ministry of Science and Technology, and Professor of Beijing  Traditional Chinese Medicine University,who on behalf of the project team have signed an agreement with the Amway (China) R&D Center.The two sides will cooperate to establish a platform for the demonstration of R&D and technical system of evaluation in terms of compound health products based on Chinese traditional medicine. Which helps to promote the standardization, modernization and internationalization of traditional Chinese medicine.

In 2015, the Amway China Plant R&D Center with a total investment of more than 200 million yuan was completed in Wuxi. It is dedicated to the research of organic planting and extracts of Chinese herbal medicine plants, and cooperates with Academician Zhu Zhaoliang from the Nanjing Institute of Soil Science of the Chinese Academy of Sciences to establish an enterprise-academician workstation,looking forward to solve the issues encountered in the development of Chinese herbal medicines like agricultural pollution, efficacy safety and sustainable development. 

The "Traditional Chinese Medicine Modernization Research" project is the second project that Amway has participated in the National 13th Five-Year Plan after participating in "Demonstration on Prevention and Control Technology of Agricultural Non-point Source Pollution and Heavy Metal Pollution In The Lower Reaches of The Yangtze River" in 2016, the 13th Five-Year Key Science and Technology Project. In 2017, Amway Plant Research and Development Center cooperated with the Institute of Chinese Medicine of China Academy of Chinese Medical Sciences to complete the full-length transcriptome genetic information excavation of chrysanthemum, allowing China to be the first country in the world to complete the whole genome sequencing of chrysanthemum.

The Chinese Source:

安利（中國）研發中心助力“中醫藥現代化”

2019年9月20至22日，第十四屆全國營養科學大會暨第十一屆亞太臨床營養大會、第二屆全球華人營養科學家大會在南京召開。本屆會議主題為“營養研究與臨床實踐”，旨在推進實施“健康中國”戰略，落實國民營養計劃（2017-2030）健康目標，促進與亞太地區及國際營養科學的交流和發展。

22日，國家十三五科技部重點研發計劃“中醫藥現代化研究”專項首席科學家、北京中醫藥大學王林元教授代表項目組與安利（中國）研發中心簽署協議，雙方合作建立“基于辨證保健的中藥復方保健產品評價技術體系研究及示范研發平臺”，推進中醫藥的標準化、現代化、國際化。

2015年，總投資超過2億元的安利中國植物研發中心在無錫落成，致力于中草藥植物的有機種植研究、提取物研究，并與中國科學院南京土壤研究所朱兆良院士合作建立企業院士工作站，解決中草藥發展中遇到的農業污染、功效安全以及可持續發展等問題。

此次參與“中醫藥現代化研究”專項，是繼2016年安利植物研發中心參與十三五重點科技項目“長江下游農業面源污染和重金屬污染防控技術示范”后，安利再度參與國家十三五重點項目。2017年，安利植物研發中心與中國中醫科學院中藥研究所合作，完成了杭白菊的全長轉錄組遺傳信息發掘，使我國成為世界上首次完成菊屬植物菊花全基因組測序的國家。